Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
'Sustainable CDMO' Samsung Biologics releases 2022 ESG Report 2022-07-11 19:00
SCG Cell Therapy Announces U.S FDA Clearance of Investigational New Drug Application for SCG101, SCG's Novel TCR-T Cell Therapy For Hepatitis B-related Liver Cancers 2022-07-11 13:34
Kevin Richardson appointed as CEO, Telix Americas 2022-07-11 08:13
Industry Empowered by Science: Guangming Science City Lures Talent Globally 2022-07-08 15:38
Biotech Startup Noul Releases 2021 Sustainability Report 2022-07-08 15:00
NEW EARLY BREAST CANCER DRUG TO REDUCE RISK OF RECURRENCE OR DEATH NOW AVAILABLE IN THE PHILIPPINES 2022-07-08 09:28
Meridian Bioscience, Inc. Enters into Agreement to Be Acquired by SD Biosensor and SJL Partners in $1.53 Billion All-Cash Transaction 2022-07-08 08:41
Billion-Euro Market Biotechnology: Exyte Builds mRNA Competence Center for WACKER in Halle 2022-07-08 06:58
HaemaLogiX strengthens Board with appointment of Dr. Geoff Nichol 2022-07-08 05:30
SunHo Announces First Patient Dosed in Phase 1/2 Clinical Trial of Two First-in-class Immunocytokines: IAP0971 and IAE0972 2022-07-07 20:00
Zhiyi Biotech Raised $45 Million in Series B Funding Round to Accelerate the Clinical Development of LBPs Pipelines 2022-07-07 17:45
Deep Longevity Published and Granted the First Microbiomic Aging Clock Patent 2022-07-07 12:18
WuXi STA Opens New Large-scale Oligonucleotide and Peptide Manufacturing Facility 2022-07-07 08:00
Brii Biosciences Announces Commercial Launch of its Amubarvimab/Romlusevimab Combination Therapy for COVID-19 in China 2022-07-07 07:10
Global Cord Blood Corporation Obtained Injunction Order Against Blue Ocean in respect of Purported EGM 2022-07-07 04:16
Alterity Therapeutics Doses First Patient in ATH434 Phase 2 Clinical Trial in Multiple System Atrophy 2022-07-06 23:00
US FDA AWARDS RARE PEDIATRIC DISEASE DESIGNATION (RPDD) TO PAXALISIB FOR AT/RT, A RARE FORM OF CHILDHOOD BRAIN CANCER 2022-07-06 19:00
Guardant Health and Adicon announce strategic partnership to offer comprehensive genomic profiling tests to accelerate development of new cancer therapies in China 2022-07-06 18:17
Inmagene and HUTCHMED Announce First Participants in Global Phase I Trial of IMG-007 2022-07-06 12:00
Deep Longevity Announces Important Operational Update 2022-07-06 10:54
1 166 167 168 169 170 452